In a broader sense, the RNA-binding sites of RBPs have garnered attention in the context of disease and drug targeting; for example, the RNA binding site in the intrinisically disordered region of TDP43 contributes to its aggregation in amyotrophic lateral sclerosis (see ref. 17). This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.